FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Company News
November 21, 2017 / 1:27 PM / 9 months ago

BRIEF-Health Canada approves update for Novo Nordisk's Victoza

Reuters Staff

1 Min Read

Nov 21 (Reuters) - Novo Nordisk

* Says Health Canada has approved a product monograph update for Victoza (liraglutide)​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    © 2018 Reuters. All Rights Reserved.